Please assess the completion status of the following clinical trial:

Trial Title: AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients satisfying the following criteria will be considered the screening population and will be eligible for participation:~* Age \> 18 years male or female.~* Scheduled for any non-mechanical valve and/or CABG (structural heart) procedure where direct access to the LAA is expected.~* No documented preoperative AF.~* CHA2DS2-VASc score of =\> 2.~* HASBLED score of =\> 2.~* Acceptable surgical candidate, including use of general anesthesia.~* Willing and able to provide written informed consent.~Exclusion Criteria:~Patients satisfying the following criteria will not be eligible for participation:~* Redo cardiac surgery.~* Mechanical heart valve or other anticipated or current requirement for anticoagulation therapy during the post-operative (30 day) period.~* Hypercoagulability conditions that may confound the study.~* Ejection Fraction \< 30.~* Left Atrium \> 6 cm.~* Severe Diastolic Dysfunction.~* Requires anticoagulation therapy.~* Patient had a stroke/cerebrovascular accident (CVA) within previous 30 days prior to signing informed consent.~Intra-Operative Exclusion Criteria~* Presence of thrombus in the left atrium or LAA.~* LAA tissue is deemed friable or has significant adhesions (as evaluated by the surgeon) near or on the LAA making AtriClip placement overly risky.~* Left atrial appendage is outside the range of manufacturer's recommendations - width \< 29mm or \> 50mm.~* Direct visualization access is not available for AtriClip placement.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LAA Exclusion with AtriClip® (Type: OTHER): LAA Exclusion with AtriClip®: AtriClip® is used per label and is not experimental.
- Medical Management (Type: ACTIVE_COMPARATOR): Medical Management: Standard of Care Oral Anticoagulation Therapy at the discretion of the Investigator.

Based on this trial design, predict the completion outcome and termination type (if applicable).